Zerion Pharma is a pharmaceutical company based in Denmark, founded in 2019, with a focus on transforming the landscape for formulation of poorly soluble drugs. The company's slogan, "Zerion Pharma is a pharmaceutical company transforming the landscape for formulation of poorly soluble drugs," encapsulates its mission succinctly. Zerion Pharma aims to address the therapeutic potential of poorly soluble drugs by leveraging its proprietary formulation platform. The company is committed to developing new treatment options across all small molecule therapy areas, thereby improving existing drug products. Zerion Pharma is not only building an internal pipeline but also partnering with originators to enable the early-stage development of drug molecules, reflecting a collaborative approach to make a positive impact on patients globally. As of now, there is no public information available about the last investment or the last investment investors in Zerion Pharma. The pharmaceutical industry is highly competitive yet integral for public health, offering potential opportunities for growth and innovation. Zerion Pharma's dedication to addressing the unmet needs of patients through formulation advancements positions the company with promising prospects in the pharmaceutical sector.
There is no investment information
No recent news or press coverage available for Zerion Pharma.